Page last updated: 2024-08-17

edetic acid and su 11248

edetic acid has been researched along with su 11248 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JY; Fields, GB; Hart, PJ; Hodder, PS; Jiang, J; Minond, D; Roush, WR; Spicer, TP; Taylor, AB	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Beijnen, JH; Huitema, AD; Lankheet, NA; Rosing, H; Schellens, JH; Steeghs, N	1

Reviews

1 review(s) available for edetic acid and su 11248

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for edetic acid and su 11248

Article	Year
Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring. Therapeutic drug monitoring, 2013, Volume: 35, Issue:2 Topics: Chromatography, Liquid; Drug Monitoring; Edetic Acid; Humans; Indoles; Pyrroles; Spectrometry, Mass, Electrospray Ionization; Sunitinib; Tandem Mass Spectrometry	2013

Article

Year

Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring.

Therapeutic drug monitoring, 2013, Volume: 35, Issue:2

Topics: Chromatography, Liquid; Drug Monitoring; Edetic Acid; Humans; Indoles; Pyrroles; Spectrometry, Mass, Electrospray Ionization; Sunitinib; Tandem Mass Spectrometry

2013

Other Studies

1 other study(ies) available for edetic acid and su 11248

Article	Year
Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro. Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22 Topics: Animals; Binding Sites; Cartilage; Cartilage, Articular; Cattle; Chemistry, Pharmaceutical; Collagen; Collagenases; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Design; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Mice; Microsomes; Molecular Conformation; Osteoarthritis; Protein Binding; Protein Conformation; Rats; Structure-Activity Relationship	2014

Article

Year

Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.

Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22

Topics: Animals; Binding Sites; Cartilage; Cartilage, Articular; Cattle; Chemistry, Pharmaceutical; Collagen; Collagenases; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Design; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Mice; Microsomes; Molecular Conformation; Osteoarthritis; Protein Binding; Protein Conformation; Rats; Structure-Activity Relationship

2014